Login / Signup

Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.

Adele ChimentoFrancesca De AmicisRosa SirianniMaria Stefania SinicropiFrancesco PuociIvan CasaburiCarmela SaturninoVincenzo Pezzi
Published in: International journal of molecular sciences (2019)
Resveratrol (3,5,4'-trihydroxystilbene; RSV) is a natural nonflavonoid polyphenol present in many species of plants, particularly in grapes, blueberries, and peanuts. Several in vitro and in vivo studies have shown that in addition to antioxidant, anti-inflammatory, cardioprotective and neuroprotective actions, it exhibits antitumor properties. In mammalian models, RSV is extensively metabolized and rapidly eliminated and therefore it shows a poor bioavailability, in spite it of its lipophilic nature. During the past decade, in order to improve RSV low aqueous solubility, absorption, membrane transport, and its poor bioavailability, various methodological approaches and different synthetic derivatives have been developed. In this review, we will describe the strategies used to improve pharmacokinetic characteristics and then beneficial effects of RSV. These methodological approaches include RSV nanoencapsulation in lipid nanocarriers or liposomes, nanoemulsions, micelles, insertion into polymeric particles, solid dispersions, and nanocrystals. Moreover, the biological results obtained on several synthetic derivatives containing different substituents, such as methoxylic, hydroxylic groups, or halogens on the RSV aromatic rings, will be described. Results reported in the literature are encouraging but require additional in vivo studies, to support clinical applications.
Keyphrases
  • respiratory syncytial virus
  • respiratory tract
  • drug delivery
  • drug release
  • anti inflammatory
  • cancer therapy
  • systematic review
  • multidrug resistant
  • case control
  • room temperature
  • cerebral ischemia